Melatonin prevents age-related hearing loss in the murin experimental model

Braz J Otorhinolaryngol. 2022 Nov-Dec;88 Suppl 3(Suppl 3):S103-S108. doi: 10.1016/j.bjorl.2022.06.002. Epub 2022 Jun 14.

Abstract

Objective: The present study aimed to perform a morphological and morphometric analysis of cochlear structures of C57BL/6J mice receiving oral melatonin for a 12-month period.

Methods: 32 male C57BL/6J were divided into control and melatonin groups. Control received saline and ethanol solution and melatonin group, 50 μL of 10 mg of melatonin/kg/day orally for a 12-month period. After de experiment the animals were sacrificed into a 40% concentration of CO2 chamber, and the blades were morphological and morphometrically analyzed.

Results: The melatonin group revealed a higher median density of viable cells (45 ± 10.28 cells/100 μm2, 31-73, vs. 32 ± 7.47 cells/100 μm2, 25-48). The median area of stria vascularis was 55.0 ± 12.27 cells/100 μm2 (38-80) in the control, and 59.0 ± 16.13 cells/100 μm2 (40-134) in the melatonin group. The morphometric analysis of the spiral ligament reveals a higher median of total viable neurons in the melatonin (41 ± 7.47 cells/100 μm2, 27-60) than in the control group (31 ± 5.68 cells/100 μm2, 21-44).

Conclusion: Although melatonin is a potent antioxidant, it does not completely neutralize the occurrence of presbycusis; however, it may delay the onset of this condition.

Keywords: Age related hearing loss; Melatonin; Outer hair cells.

MeSH terms

  • Animals
  • Male
  • Melatonin* / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Models, Theoretical
  • Presbycusis* / prevention & control
  • Stria Vascularis

Substances

  • Melatonin